ASH 2023: MRD Highlights in BioPharma Drug Development

Read More

The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myeloma

Premal DL., et al.
Science Translational Medicine
September 2020
Authors and Affiliates
Premal D Lulla 1, Ifigeneia Tzannou 2, Spyridoula Vasileiou 2, George Carrum 2, Carlos A Ramos 2, Rammurti Kamble 2, Tao Wang 2, Mengfen Wu 2, Mrinalini Bilgi 2, Adrian P Gee 2, Shivani Mukhi 2, Betty Chung 2, Linghua Wang 2, Ayumi Watanabe 2, Manik Kuvalekar 2, Mira Jeong 2, Yumei Li 2, Shamika Ketkar 2, Matthew French-Kim 2, Bambi Grilley 2, Malcolm K Brenner 2, Helen E Heslop 2, Juan F Vera 2, Ann M Leen 2; 1 Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX 77030, USA 2 Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX 77030, USA